Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
PubMed laboratory research record [PMID: 30783379] PubMed record related to this compound for laboratory literature review
The article puts semaglutide patent expiry between 2027 and 2033 depending on formulation and jurisdiction, and says tirzepatide runs later, with some patents extending to 2038 or 2040
BPC-157 is a synthetic peptide compound supplied by PRIME STATE strictly for research and educational purposes
There is no risk of exceeding regulatory limits
US$ 24.74
US$ 21.22
US$ 29.16
.webp)
US$ 22.31
US$ 25.08
US$ 23.04
US$ 22.60
US$ 26.70
US$ 26.95
US$ 20.47
US$ 24.17
US$ 29.23
US$ 22.15
